Molecular Arrays

These unique biochip assays permit high discrimination between multiple
targets in a number of genes with a rapid turnaround time (3 hours).
The arrays enable detection of the most frequently occurring mutations known to cause disease (FH) and adversely affect patient treatment (KRAS, BRAF, PIK3CA). A unique primer set is designed for each target which will hybridise to a complementary oligo-nucleotide probe spotted on a biochip discrete test region (DTR).